

Nisoldipine XR is an extended-release calcium channel blocker for high blood pressure. Learn its uses, dosage, who should avoid it, and what it costs in 2026.
If your doctor has prescribed Nisoldipine XR — or you've seen it mentioned as a treatment option for hypertension — you probably have questions. What is it? How does it work? What makes it different from other blood pressure medications? This guide covers everything you need to know about Nisoldipine XR in 2026, from its FDA-approved uses to dosing, costs, and important safety information.
Nisoldipine XR is a prescription medication in the dihydropyridine calcium channel blocker (CCB) class. It was originally sold under the brand name Sular, which has since been discontinued (not for safety reasons — the FDA confirmed in 2014 that the withdrawal was a business decision). Today, Nisoldipine XR is available only as a generic, manufactured primarily by Emcure Pharmaceuticals USA.
The "XR" stands for extended-release, meaning the medication is designed to release slowly throughout the day so you only need to take it once daily.
You may see it referred to by several names: Nisoldipine, Nisoldipine XR, Nisoldipine ER, Nisoldipine extended-release, Sular, or generic Sular. They're all the same active ingredient.
Nisoldipine XR is FDA-approved for treating hypertension (high blood pressure) in adults. It can be used alone or combined with other blood pressure medications like ACE inhibitors, ARBs, beta-blockers, or diuretics.
Some doctors prescribe Nisoldipine XR off-label for:
Off-label use means the medication hasn't been specifically FDA-approved for that condition, but your doctor may determine it's appropriate based on clinical evidence.
No. Nisoldipine XR is not a controlled substance and has no DEA schedule. It doesn't carry any risk of addiction or dependence.
Nisoldipine XR comes as an extended-release tablet in several strengths:
For details on how Nisoldipine XR works in your body, see our mechanism of action guide.
Nisoldipine XR is not appropriate for everyone. You should not take it if you have:
Your doctor should know if you have:
Nisoldipine XR has no FDA boxed warning. For a full list of potential side effects, read our side effects guide.
Nisoldipine XR is one of the more expensive calcium channel blockers, mainly because it has limited generic manufacturers:
By comparison, Amlodipine — the most widely prescribed calcium channel blocker — costs $4-$10 per month as a generic. This price difference is one reason Nisoldipine XR isn't prescribed as frequently.
There are no manufacturer savings programs currently available for Nisoldipine XR (the brand Sular is discontinued). However, you can find coupons, discount cards, and patient assistance options to help reduce costs.
Nisoldipine XR belongs to the same drug class as several other calcium channel blockers. Here's how it compares:
Your doctor may prescribe Nisoldipine XR if you haven't responded well to other CCBs or if there's a specific clinical reason to choose it. For a deeper comparison, see our guide on alternatives to Nisoldipine XR.
Nisoldipine XR is a well-established blood pressure medication that works effectively for many patients. While it's not the most commonly prescribed calcium channel blocker — and it comes with some unique requirements like avoiding grapefruit and taking it on an empty stomach — it's a legitimate option for hypertension management.
The main challenges in 2026 are availability and cost. With limited manufacturers and no brand version, finding it at pharmacies can take some effort. But tools like Medfinder can help you locate it, and discount programs can make it more affordable.
If you have questions about whether Nisoldipine XR is the right medication for you, talk to your doctor. And if you're having trouble finding it, you're not alone — check out our guide on how to find Nisoldipine XR in stock near you.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.